RENAISSANCE TECHNOLOGIES LLC
Position in ALLO — Allogene Therapeutics, Inc.
CIK 1037389
NEW YORK, NY
Position in ALLO
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$5,219,960
+$2,223,655 QoQ
Shares Held
2,139,328
-2.2% QoQ
Ownership
0.620%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALLO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,450,872,574 across 330 Biotechnology names. ALLO ranks #78 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,726,993 | $588,750,729 | |
| 2 | INCY |
Incyte Corp
|
3,651,532 | $343,682,191 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
5,682,783 | $229,072,982 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
421,688 | $188,300,559 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
819,374 | $154,902,654 | |
| 6 | GMAB |
Genmab A/S
|
4,414,550 | $118,442,376 | |
| 7 | INVA |
Innoviva, Inc.
|
4,055,632 | $94,496,225 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
1,036,495 | $64,988,236 |
All Filings in ALLO
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,219,960 | 2,139,328 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,996,305 | 2,187,084 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,588,326 | 2,893,812 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,887,113 | 1,670,012 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,272,782 | 1,556,700 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,181,172 | 554,541 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,797,625 | 642,009 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $4,072,735 | 1,747,955 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,774,143 | 396,900 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,472,260 | 458,648 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $95,993 | 30,282 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,251,943 | 251,900 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,117,778 | 428,700 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,768,229 | 440,100 | Shares | Sole | 2023-02-13 | |
| 2022-03-31 | $8,879,517 | 974,700 | Shares | Sole | 2022-05-13 | |
| 2021-06-30 | $18,370,752 | 704,400 | Shares | Sole | 2021-08-13 | |
| 2020-09-30 | $3,163,869 | 83,900 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,079,064 | 25,200 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||